Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07163078 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Nutrition Supplement for Cystic Fibrosis

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 33 days later Dec 2026 → Feb 2, 2027
See other at-risk trials from Ohio State University

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 2026 to Oct 15, 2026 Show 6 more changesShow less
    • Primary completion pushed from Dec 2026 to Feb 2, 2027
    • Study completion date: Jan 2027 to Feb 2, 2027
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints: details revised at 4 of 5 entries
    • Site details revised
    • Publications: details revised at 1 of 1 entry
  2. Primary completion date: Mar 28, 2026 to Dec 2026
    • Start date: Jan 15, 2026 to Jun 2026
    • Study sites: 0 to 1
    • Study completion date: Apr 27, 2026 to Jan 2027
    v3
  3. Start date: Sep 30, 2025 to Jan 15, 2026v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to learn if one nutrition supplement formula works better than a different formula in adults with cystic fibrosis. The main question being addressed is: Will certain atypical versions of certain nutrients outperform typical versions of these nutrients? This will be determined by examining blood measures of nutrient levels and/or indications of nutrient function indicators pre- and post-intervention. Participants will take the supplements for 6 weeks with a blood draw before and after that time.
Trial Details
NCT Number NCT07163078
Lead Sponsor Ohio State University
Conditions
(from sponsor)		 Cystic Fibrosis (CF)
Related terms Cystic Fibrosis
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov